Explore more publications!

LATAM News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.

Press releases published on November 13, 2025

Dynacor Reports Record Sales and EBITDA in Q3-2025
PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
Dynacor annonce des ventes et un BAIIA records au troisième trimestre de 2025
Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
Applied Therapeutics Reports Third Quarter 2025 Financial Results 
Critical One Energy Appoints Chief Geological Officer to Advance Flagship Antimony-Gold Project
Top Traders, Assemble! HTX Trading Championship Team Challenge Officially Starts, Team Up to Compete for the $400,000 Prize Pool
Americas Gold and Silver Accelerates Silver Growth in Idaho via the Proposed Strategic Acquisition of the Neighbouring Crescent Silver Mine and Announces Concurrent US$65 Million Bought Deal Financing
Angelini Ventures to support Singapore biotech ecosystem development with first Asia office  
Day One Biopharmaceuticals to Acquire Mersana Therapeutics
ITM Announces FDA Acceptance of New Drug Application (NDA) and PDUFA Date for n.c.a. 177Lu-edotreotide (ITM-11) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
4TEEN4 Extends Series C Financing Round to €55 Million, Supporting Expanded Clinical Development of Procizumab in Cardiogenic Shock
Bitget ilumina UNTOLD Dubái con una torre LED inmersiva y una experiencia de clase mundial para los aficionados
Bitget illumine UNTOLD Dubai avec une tour LED immersive et une expérience mondiale pour les fans
ビットゲット (Bitget)、没入型LEDタワーとグローバルファン体験でアントールド・ドバイ (UNTOLDドバイ) をライトアップ
Bitget, 몰입형 LED 타워와 글로벌 팬 체험으로 UNTOLD 두바이를 빛내다
Bitget menceriakan UNTOLD Dubai dengan Menara LED Imersif dan Pengalaman Peminat Global
Bitget 以沉浸式 LED 塔与全球粉丝体验点亮迪拜 UNTOLD 音乐节
IMU Biosciences announces formation of Scientific Advisory Board
Enterome to present positive interim Phase 2 data for lead OncoMimics™ immunotherapy EO2463 in follicular lymphoma at American Society for Hematology (ASH) meeting

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions